Underlying mechanisms of multi-organ manifestations and exacerbated inflammation in
COVID-19 are yet to be delineated. The hypothesis of SARS-CoV-2 triggering autoimmunity …

Objectives The coronavirus disease 2019 (COVID-19), caused by the novel betacoronavirus
severe acute respiratory syndrome 2 (SARS-CoV-2), was declared a pandemic in March …

SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or …

Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan,
China, in December 2019, the novel coronavirus that causes this disease—severe acute …

Improved understanding and management of COVID-19, a potentially life-threatening
disease, could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward …

Antibodies are key immune effectors that confer protection against pathogenic threats. The
nature and longevity of the antibody response to SARS-CoV-2 infection are not well defined …

Significant time has passed since the coronavirus disease of 2019 (COVID-19) pandemic
outbreak, which led to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

Since its emergence in December 2019, it took only a couple of months for an outbreak of
the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World …

As SARS-CoV-2 infections and death counts continue to rise, it remains unclear why some
individuals recover from infection, whereas others rapidly progress and die. Although the …

Summary Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging
from asymptomatic to life-threatening, yet the relationship between severity and the humoral …